Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease. - Test2 - elhamkhani - TriplyDB

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

http://www.wikidata.org/entity/Q34159183

about

Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons.Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.

P2860

Q35819324-9EFCC574-4689-4DD4-91A9-CFBCCE42A3F8 Q36293826-45862ADD-5F92-458B-9C30-9DC38BDDCADE Q37369400-1E78B470-1A6B-4F40-BB1F-7B93CBF0439D Q38530085-7D64A8F3-F1BB-491F-BBE8-12C54B7FA584

P2860

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

http://www.wikidata.org/entity/Q34159183

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

@ast

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

@en

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

@nl

type

label

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

@ast

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

@en

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

@nl

prefLabel

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

@ast

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

@en

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease.

@nl

P1433

Q34159183-F025301B-5467-4B83-9D3A-406DF087A7FF

P1476

Q34159183-7AF05C89-B3E7-49DE-B1D3-A724020D4E4D

P2093

Q34159183-0708B27A-04D9-4FF8-B552-2EB3A6F2AC32

Q34159183-852FF5A9-6696-449D-882E-BA14A0969F9E

Q34159183-88A79389-D582-42D2-95B1-B10EFD3F0FF2

Q34159183-8D2914A4-352A-4249-9DAE-EE141DAB4822

Q34159183-957FBA9C-AEF8-4996-8EEB-70FC683ECA65

Q34159183-B751827D-803C-4938-AAD0-12C338518E23

Q34159183-BEEC381C-B5C6-492B-A0DD-44E76438C1E3

P2860

Q34159183-0AD26741-CA36-41CA-896C-FA463CF4B0F9

Q34159183-15302959-175F-4940-A16E-B71521BC3C65

Q34159183-27BED50E-4E81-4DC2-89D3-1DB9B9ED8A0D

Q34159183-288159BA-3DEA-4106-B172-F631BE6D5017

Q34159183-32C51BA4-D6D7-4ECD-B53D-8273221B2A72

Q34159183-33848C7C-077E-4305-879D-BE79E527AE54

Q34159183-3A3B797D-8911-430E-8FB2-AABE4A1044A0

Q34159183-40D70F3A-4F54-4957-924D-AB23C3BF2C27

Q34159183-451C9838-DB14-4B1E-8068-023066318022

Q34159183-63B22FD5-E9C2-460D-A08C-0403A250CDD3

P304

Q34159183-FEF69AAA-C895-4FEA-9B8E-7A38D792E52A

P31

Q34159183-AC2DDC1C-0ABD-4797-9982-10A3D358B64E

P356

Q34159183-C92964B8-5C51-4D7B-8B81-66CF705F5845

P478

Q34159183-006B09F5-B5F4-4414-9A96-76E7EBC0B03A

P50

Q34159183-0CD08166-423A-40AB-971B-7264E7401595

Q34159183-1078FDE2-220D-421D-B1DA-B68CBCD8527C

Q34159183-58B6E416-29D6-4153-A0D4-DBA7227ABDF9

Q34159183-83C199EC-7367-4CAC-AD12-48E61A592F9C

Q34159183-D15CB66C-BF05-4992-84A5-18B40D3320FC

P577

Q34159183-506A35B2-FB86-4E13-BA97-27F219160B3F

P5875

Q34159183-109D23E2-1278-4600-8993-F95C497E1536

P698

Q34159183-656A77F8-564E-497E-AB97-4B79B78AAAB5

P921

Q34159183-254250D8-8CCB-4CAC-8E3B-7DAE11832C25

Q34159183-A6D81FF9-EEDE-4658-BD2D-BFEBA6301C75

P932

Q34159183-071BCF43-69CD-4C43-B1CE-D1629060B637

P356

FNAGI.2014.00239

P1433

Frontiers in Aging Neuroscience

P1476

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease

@en

P2093

Christoph P Dohm

http://www.w3.org/2001/XMLSchema#string

Eva M Szegö

http://www.w3.org/2001/XMLSchema#string

Kim-Ann Saal

http://www.w3.org/2001/XMLSchema#string

Mathias Bähr

http://www.w3.org/2001/XMLSchema#string

Patrizia Hause

http://www.w3.org/2001/XMLSchema#string

Vivian Dambeck

http://www.w3.org/2001/XMLSchema#string

Zara D Hedouville

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease

Alpha-synuclein in Lewy bodies

Parkinson's disease: mechanisms and models

{alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics.

Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.

Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.

alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.

α-Synuclein modulates neurite outgrowth by interacting with SPTBN1.

P304

239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNAGI.2014.00239

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Lars Tatenhorst

P577

2014-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266947195

http://www.w3.org/2001/XMLSchema#string

P698

25309425

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4159996

http://www.w3.org/2001/XMLSchema#string